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Lung transplantation is the last resort for patients affected by several end-stage lung diseases, such 
as cystic fibrosis and chronic obstructive pulmonary disease, which have not improved with other 
available treatments. Risks associated with this procedure include acute and chronic rejection of the 
transplanted organs, which are recognized as non-self by the immune system. Chronic lung allograft 
dysfunction (CLAD), a major cause of long-term allograft failure, is considered a form of chronic 
allograft rejection. Two major phenotypes of CLAD are bronchiolitis obliterans syndrome and 
restrictive CLAD, both characterized by loss of respiratory function. The etiology of CLAD is still not 
clarified, and, despite evidence that viral infections are linked to this syndrome, the association has 
not been confirmed.  
For this reason, Dr. Cynthia Fisher and colleagues from the Vaccine and Infectious Disease Division 
at Fred Hutch and the University of Washington, designed a retrospective study to identify whether 
respiratory viral infections are associated with CLAD. "Lung transplantation is a life-saving treatment 
for a broad range of advanced lung diseases, but outcomes are worse than all other organ 
transplants. The single most common cause of late allograft failure and death in lung transplant 
recipients (LTRs) is chronic lung allograft dysfunction (CLAD), a progressive, irreversible, and 
currently untreatable process leading to obliteration of small airways," explained Dr. Fisher. 
Their study, published in the December issue of Clinical Infectious Diseases, utilized a vast cohort of 
subjects undergoing lung transplantation at the University of Washington and relied upon state-of-
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the-art diagnostic tests for twelve upper and lower respiratory tract infections. CLAD was defined 
following the most recent guidelines, as a 20% decrease of forced expiratory volume lasting at least 
three weeks. Fifty out of 250 patients were diagnosed with CLAD, at a median of 95 weeks post-
transplantation. CLAD was associated with a higher mortality rate. Almost 32% of transplanted 
patients were affected by viral respiratory infection, mostly rhinovirus, followed by parainfluenza and 
influenza infections. Acquisition of a viral infection was independently associated with CLAD, and the 
association was stronger for shorter modeled periods of risk following the respiratory virus episode 
but was also present when the whole follow-up time was analyzed. The study also compared the 
association of viral infection with the two phenotypes of CLAD separately. Although the numbers 
were too low to perform statistical analyses, a higher percentage of restrictive CLAD had at least one 
preceding viral episode.  
The study, by analyzing a large cohort of patients, and by using molecular techniques to detect 
several viruses, gives a clear answer as to whether respiratory viral infection can be linked to a form 
of chronic rejection of lung transplant. "Our study suggests that respiratory virus infection (RVI) may 
be a major contributor to CLAD development. This association is relevant as RVI could represent a 
distinct, diagnosable, and potentially treatable major cause of allograft dysfunction and loss in LTRs, 
particularly as there are several new anti-virals currently in clinical trial." said Dr. Fisher. Indeed, the 
results of the study she led are clinically substantial, and support the importance of preventing viral 
infections as a fundamental part of post-transplant care. 
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